We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRLA
226
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
$155K 0.01%
14,182
-58,816
-81% -$645K
ISRLW
227
DELISTED
Israel Acquisitions Corp Warrant
ISRLW
$152K 0.01%
2,382,596
+1,226,605
+106% +$130K
JSPRW icon
228
Japer Therapeutics Warrants
JSPRW
$102K
$148K 0.01%
1,849,796
+979,440
+113% +$81.3K
VCXB
229
DELISTED
10X Capital Venture Acquisition Corp III
VCXB
$145K 0.01%
+13,600
New +$145K
VHAQ
230
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$138K 0.01%
12,259
DISH
231
DELISTED
DISH Network Corp.
DISH
$130K 0.01%
22,500
FREEW
232
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$130K 0.01%
1,622,732
+486,909
+43% +$48.9K
SLAMW
233
DELISTED
Slam Corp. warrant
SLAMW
$129K 0.01%
679,207
+269,387
+66% +$33.6K
ABUS icon
234
Arbutus Biopharma
ABUS
$928M
$125K 0.01%
+50,000
New +$97.9K
CVIIW
235
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$124K 0.01%
950,264
+520,759
+121% +$86.5K
LANV.WS
236
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$123K 0.01%
881,058
+143,114
+19% +$19.3K
BETR icon
237
Better Home & Finance Holding
BETR
$302M
$122K 0.01%
3,000
-1,906
-39% -$45.7K
ENGNW icon
238
enGene Therapeutics Warrants
ENGNW
$5M
$118K 0.01%
+138,712
New +$107K
BRACR
239
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$114K 0.01%
973,734
-11,600
-1% -$1.54K
RNWWW
240
ReNew Energy Global PLC Warrant
RNWWW
$27.8K
$114K 0.01%
+100,000
New +$73.7K
ESHAR
241
DELISTED
ESH Acquisition Corp Right
ESHAR
$111K 0.01%
1,012,273
+927,744
+1,098% +$139K
BUJAR
242
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$111K 0.01%
851,579
+133,667
+19% +$19.7K
TNGX icon
243
Tango Therapeutics
TNGX
$4.39B
$99K 0.01%
+10,000
New +$86.8K
DNA.WS
244
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$97.7K 0.01%
927,569
+484,367
+109% +$71.3K
RGTIW icon
245
Rigetti Computing Warrants
RGTIW
$175M
$94.3K 0.01%
+698,293
New +$135K
PERF.WS
246
DELISTED
Perfect Corp Warrants
PERF.WS
$93.7K 0.01%
1,252,508
+998,995
+394% +$52.4K
BETRW icon
247
Better Home & Finance Warrant
BETRW
$1.82M
$89.2K 0.01%
557,723
+2,183
+0.4% +$236
LSEAW
248
DELISTED
Landsea Homes Corporation Warrant
LSEAW
$88.9K 0.01%
+250,250
New +$52.8K
AUR icon
249
Aurora
AUR
$13.8B
$87.4K 0.01%
20,000
-480,000
-96% -$1.19M
EOSE icon
250
Eos Energy Enterprises
EOSE
$1.52B
$81.8K 0.01%
+75,000
New +$109K

Similar funds

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.